Late (>5 years) regional lymph node metastasis of oral squamous cell carcinoma (SCC), proven by p53 mutation analysis

Journal of Cranio-Maxillofacial Surgery

Volumn 36, Issue 7, 2008, Pages 415-418

  Hoekstra, Jan Willem M ^a   Kummer, J Alain ^a   van Es, Robert J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

IFN 1a; late metastasis; lymph node; p53 mutation analysis; second primary tumour; squamous cell carcinoma

Indexed keywords

ALCOHOL; COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53; RNA;

ACCESSORY NERVE; ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; DNA SYNTHESIS; FOLLOW UP; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MASTOIDECTOMY; MOUTH CARCINOMA; RADIATION DOSE; RNA ISOLATION; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYTOSINE; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH FLOOR; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASMS, SECOND PRIMARY; POINT MUTATION; THYMINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 50949128893     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2008.04.002     Document Type: Article

References (12)

1. Achiron A., Barak Y., Gail M., Mandel M., Pee D., Ayyagari R., and Rotstein Z. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Res Treat 89 (2005) 265-270
2. Brickelmaier M., Carmillo A., Goelz S., Barsoum J., and Qin X.Q. Cytotoxicity of combinations of IFN-β and chemotherapeutic drugs. J Interferon Cytokine Res 22 (2002) 873-880
3. Dutch Head & Neck Working Group: Guideline Oral- and Oropharynxcarcinoma. Nederlandse Werkgroep Hoofd- Halstumoren: Richtlijn Mondholte- en Orofarynxcarcinoom (2004), Van Zuiden Communications, Alphen aan den Rijn
4. Greenblatt M.S., Bennett W.P., Hollstein M., and Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54 (1994) 4855-4878
5. Kropveld A., Rozemuller E.H., Leppers F.G.J., Scheidel K.C., De Weger R.A., Koole R., Hordijk G.J., Slootweg P.J., and Tilanus M.G. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest 79 (1999) 347-353
6. Netterville J.L., Sinard R.J., Bryant Jr. G.L., and Burkey B.B. Delayed regional metastasis from midfacial squamous carcinomas. Head Neck 20 (1998) 328-333
7. Nielsen N.M., Rostgaard K., Rasmussen S., Koch-Henriksen N., Storm H.H., Melbye M., and Hjalgrim H. Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer 118 (2006) 979-984
8. Schwartz L.H., Ozsahin M., Zhang G.N., Touboul E., De Vataire F., Andolenko P., Lacau-Saint-Guily J., Laugier A., and Schlienger M. Synchronous and metachronous head and neck carcinomas. Cancer 74 (1994) 1933-1938
9. Slootweg P.J., Hordijk G.J., and Koole R. Autopsy findings in patients with head and neck squamous cell cancer and their therapeutic relevance. Eur J Cancer B Oral Oncol 32B (1996) 413-415
10. Spector J.G., Sessions D.G., Haughey B.H., Chao K.S., Simpson J., El Mofty S., and Perez C.A. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111 (2001) 1079-1087
11. Tjebbes G.W.A., Leppers vd Straat F.G.J., Tilanus M.G.J., Hordijk G.J., and Slootweg P.J. P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases. Oral Oncol 35 (1999) 348-389
12. Van Rens M.T.M., Eijken E.J.E., Elbers J.R.J., Lammers J.W.J., Tilanus M.G.J., and Slootweg P.J. P53 mutation analysis for definite diagnosis of multiple primary lung carcinoma. Cancer 94 (2002) 188-196